New Zealand markets open in 2 hours 3 minutes

NeonMind Biosciences Inc (6UF0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
0.0160-0.0010 (-5.88%)
At close: 12:05PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/11/2022
30/11/2021
30/11/2020
Cash flows from operating activities
Net income
-112.031
-2,034
-7,208
-2,677
Depreciation & amortisation
0.565
1.127
0.689
0
Stock-based compensation
-49.004
166.077
2,500
789.738
Change in working capital
308.273
528.65
112.004
-185.663
Inventory
-
-
-
-17.155
Accounts payable
46.215
285.752
493.468
194.142
Other working capital
-74.341
-1,081
-5,824
-853.447
Other non-cash items
323.696
276.727
0.611
202.373
Net cash provided by operating activities
-74.341
-1,081
-5,821
-853.447
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-3.382
-
Purchases of investments
-
0
-57.5
0
Sales/maturities of investments
-
72.14
450
0
Net cash used for investing activities
-
72.14
389.118
0
Cash flows from financing activities
Common stock issued
-
0
4,600
803.865
Other financing activities
-
-
-574.57
-65.937
Net cash used provided by (used for) financing activities
0
271
6,204
746.928
Net change in cash
-2.201
-737.708
772.355
-106.519
Cash at beginning of period
2.456
773.525
1.17
107.689
Cash at end of period
0.255
35.817
773.525
1.17
Free cash flow
Operating cash flow
-74.341
-1,081
-5,821
-853.447
Capital expenditure
-
-
-3.382
-
Free cash flow
-74.341
-1,081
-5,824
-853.447